Approval · Notice of Compliance 18838 · 2017
SEHCAT: Notice of Compliance 18838
Issued January 9, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18838
- Date
- January 9, 2017
- Company
- Ge Healthcare Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug product and drug substance manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEHCAT | Not yet assigned | — |
Medicinal ingredients
- TAUROSELCHOLIC ACID 370 KBQ per CAP